FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4902611000001106: Dipotassium clorazepate 15mg capsules 20 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22722701000001113 Dipotassium clorazepate 15mg capsules 20 capsule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22722801000001116 Dipotassium clorazepate 15mg capsules 20 capsule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dipotassium clorazepate 15mg capsules 20 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Benz) true Inferred relationship Existential restriction modifier
Dipotassium clorazepate 15mg capsules 20 capsule VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Dipotassium clorazepate 15mg capsules 20 capsule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Dipotassium clorazepate 15mg capsules 20 capsule Is pack of Product containing precisely dipotassium clorazepate 15 milligram/1 each conventional release oral capsule false Inferred relationship Existential restriction modifier
Dipotassium clorazepate 15mg capsules 20 capsule Has active ingredient Dipotassium clorazepate false Inferred relationship Existential restriction modifier
Dipotassium clorazepate 15mg capsules 20 capsule VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Dipotassium clorazepate 15mg capsules 20 capsule VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Dipotassium clorazepate 15mg capsules 20 capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Dipotassium clorazepate 15mg capsules 20 capsule Has VMP Product containing precisely dipotassium clorazepate 15 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Dipotassium clorazepate 15mg capsules 20 capsule Has specific active ingredient Dipotassium clorazepate true Inferred relationship Existential restriction modifier
Dipotassium clorazepate 15mg capsules 20 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Is a True Dipotassium clorazepate 15mg capsules 20 capsule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start